PharmaSignal
Intelligence Suite
Biopharma Intelligence, Precision Delivered.
Eight specialized digests engineered for BD executives, market access teams, investors, and clinical strategy leaders.
◆ Intelligence Verticals ◆
01 — DAILY
Strategic News Watch
Daily curated intelligence across the biopharma landscape. Pipeline moves, M&A signals, regulatory shifts — before they hit consensus.
02 — TWICE WEEKLY
Market Access Intelligence
Pricing strategy, payer dynamics, Part D redesign, IRA impact — decoded for market access teams navigating reimbursement complexity.
03 — TWICE WEEKLY
Oncology Signal
Competitive pipeline intelligence across solid tumors & hematology. ADCs, bispecifics, IO combinations, and CDx — the signals that move oncology portfolios.
04 — TWICE WEEKLY
Rare Disease & Gene Therapy
CBER regulatory dynamics, gene therapy durability data, orphan drug economics, and the competitive race across 630+ tracked rare disease terms.
05 — WEEKLY
NeuroMarket Pulse
Alzheimer’s drives attention. Migraine drives revenue. MS drives stability. Gene therapy drives narrative. Five verticals of neuro intelligence, decoded.
06 — WEEKLY
GLP-1 & Metabolic Intel
The $100B+ market in motion. Next-gen oral GLP-1s, amylin combos, MASH crossover, CKD expansion — competitive dynamics across the metabolic frontier.
07 — WEEKLY
Manufacturing Intelligence
CDMO capacity, supply chain disruptions, 483 observations, facility expansions, and the operational backbone that determines who can actually deliver at scale.
08 — WEEKLY
The Week in Review
The executive brief. One edition per week synthesizing the signal from all verticals into a single strategic narrative with forward-looking analysis.
Built for professionals who need signal, not noise.
Start Your Intelligence Feed →